Altai Protocol Library New Reference: Abemaciclib for Adjuvant Breast Cancer U. Darda Bayraktar, MD 2025-10-18
Altai Protocol Library New Reference: Alectinib for ALK-Positive Advanced NSCLC U. Darda Bayraktar, MD 2025-10-18
Altai Protocol Library New Drug: Imlunestrant for ESR1-Mutated Advanced Breast Cancer U. Darda Bayraktar, MD 2025-10-17
Altai Protocol Library New Indication: Amivantamab-Lazertinib for First Line Advanced EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2025-10-13
Multiple Myeloma New Protocol: Belantamab Mafodotin with Bortezomib/Dexamethasone for R/R Myeloma Ulas D. Bayraktar, MD 2025-09-08
Hodgkin Lymphoma New Protocol: Brentuximab – ECADD Chemo for Hodgkin Lymphoma Ulas D. Bayraktar, MD 2025-09-08
Pancreatic Cancer New Reference: Advanced Pancreatic Cancer Protocols Ulas D. Bayraktar, MD 2025-09-08
Prostate Cancer New REference: Talazoparib and Enzalutamide for HRR-Deficient Prostate Cancer Ulas D. Bayraktar, MD 2025-09-08
Renal Cell Carcinoma New Indication: Bevacizumab and Erlotinib for Papillary Renal Cell Carcinoma Ulas D. Bayraktar, MD 2025-09-08
Chronic Lymphocytic Leukemia New Reference: MRD-Guided CLL Treatment Ulas D. Bayraktar, MD 2025-09-08
